In short: Low-level laser therapy may improve hair density for some people with diagnosed androgenetic alopecia, but the evidence is based on small, short trials of specific devices. It is not a cure for every type of hair loss, and one device’s results do not validate every laser cap, helmet or comb.
Low-level laser therapy may improve hair density for some people with diagnosed androgenetic alopecia, also called pattern hair loss. The evidence is promising rather than conclusive: trials are small and short, devices vary, and positive findings for one product do not prove that every laser cap, helmet or comb works (Suchonwanit and colleagues, 2019; Khandpur and colleagues, 2023).
Confirm the cause of your hair loss before comparing devices. Hair loss can be temporary or permanent and can have several causes; the NHS hair loss guide advises seeing a GP if you are worried and getting an idea of the cause before approaching a commercial hair clinic.
What is low-level laser therapy?
Low-level laser therapy, often shortened to LLLT, uses low-intensity red or near-infrared light. It is also called low-level light therapy or photobiomodulation because products may use laser diodes, light-emitting diodes, or both (Suchonwanit and colleagues, 2019).
Devices sold for hair loss come in different shapes. The published literature describes hat-based systems such as caps and helmets, as well as brush-based systems such as combs, hairbrushes and headbands. Some cover most of the scalp without being moved; others must be passed over separate areas by hand (Suchonwanit and colleagues, 2019).
The proposed biological effects remain under investigation. The 24-week helmet trial describes possible effects on cell activity and the hair-growth cycle, but it also says the precise mechanism is not established (Suchonwanit and colleagues, 2019). A mechanism proposed in a paper is not proof that a shop-bought device will produce visible growth.
Hair transplantation removes hair from one area and places it in thinning areas, according to the NHS hair transplant guide. LLLT exposes existing follicles to low-intensity light instead of moving or creating follicles. Research on LLLT for androgenetic alopecia should not be presented as evidence that light will accelerate growth after a transplant.
Does LLLT work for androgenetic alopecia?
One sham-controlled trial gives a useful but narrow result. Forty adults with androgenetic alopecia, split evenly between men and women, were assigned to a RAMACAP laser helmet or a sham helmet for 24 weeks. Of those participants, 36 completed the study. At week 24, the laser group had greater gains in hair density and hair diameter than the sham group, with reported p values of 0.002 and 0.009 (Suchonwanit and colleagues, 2019).
Those findings apply to one helmet and one study protocol. The authors listed the small sample, lack of long-term follow-up and an imperfect sham device among the limitations. They also said questions remained about the best light source, wavelength, treatment schedule, maintenance schedule and candidate selection (Suchonwanit and colleagues, 2019).
A second randomised trial tested a laser comb as an addition to topical medical treatment in 54 men aged 18 to 45 with mild-to-moderate androgenetic alopecia. After 16 weeks, hair density had risen by 14.78% in the combined group and 11.43% in the medical-treatment-only group. The between-group difference was not statistically significant, and neither physician assessment nor patient satisfaction differed significantly between the groups (Khandpur and colleagues, 2023).
The second trial does not prove that LLLT alone is ineffective because everyone received an active medical treatment and there was no sham-only comparison. It does show why an advertised percentage increase needs its comparator: improvement from baseline is not the same as improvement beyond another treatment (Khandpur and colleagues, 2023).
Taken together, these trials support a cautious conclusion. A specific LLLT device may improve measured density or diameter in some adults with androgenetic alopecia, but the evidence does not establish a predictable result for every person, product or treatment schedule. The NHS also warns that no hair-loss treatment is completely effective.
Why do device and study details matter?
"Laser cap" is a product category, not a standard protocol. Devices can differ in light source, wavelength, energy delivered to the scalp, coverage, treatment time and how they are used. The helmet paper notes that only a small number of marketed devices had been tested in well-designed randomised controlled studies and that lasers, LEDs and mixed systems should not be treated as identical (Suchonwanit and colleagues, 2019).
Check whether a seller’s evidence matches the exact model. A study of a full-scalp helmet does not validate a comb that must be moved by hand. Evidence for a laser-only product does not automatically apply to an LED cap, and a trial using LLLT alongside medical treatment cannot establish what LLLT would achieve on its own.
Trials also use different outcome measures. Hair count or density, shaft diameter, investigator photographs and patient satisfaction answer different questions. In the 16-week add-on trial, the groups did not differ significantly in measured density, physician assessment or satisfaction, despite both groups improving from baseline (Khandpur and colleagues, 2023).
The two trials followed people for 16 and 24 weeks, so they cannot show whether any improvement persists over years, what happens after use stops or which maintenance schedule works best. The 24-week authors explicitly reported no long-term follow-up and unresolved maintenance questions (Suchonwanit and colleagues, 2019).
Before paying, ask for the paper on the exact device and compare its participants with your diagnosis. A study in adults with androgenetic alopecia does not establish effectiveness for sudden shedding, patchy loss, scarring alopecia or hair loss caused by illness. The NHS lists several temporary and permanent causes, which is why diagnosis comes first.
Who should discuss LLLT with a clinician?
The evidence covered here concerns adults diagnosed with androgenetic alopecia. If your loss is sudden, patchy, accompanied by scalp symptoms or has not been assessed, see a GP rather than assuming it is pattern loss. The NHS advises speaking to a GP when you are worried and finding the cause before visiting a commercial clinic.
If androgenetic alopecia has been diagnosed, ask a GP or dermatologist whether LLLT belongs among your options. That discussion can account for your pattern of loss, scalp health, other conditions, current treatments and the evidence for the device you are considering. This article cannot determine whether you are a suitable candidate.
You may also want to discuss how progress would be assessed. Consistent photographs and a defined clinical measure are more informative than changing lighting, hairstyle or camera angle, but photographs alone cannot diagnose a condition. In the published trials, researchers used specified measures, fixed follow-up points and comparison groups rather than relying on casual mirror checks (Suchonwanit and colleagues, 2019; Khandpur and colleagues, 2023).
Speak to your GP or a dermatologist about medical treatment. Do not stop, start or combine a treatment because a device seller suggests it, and do not treat LLLT as a reason to postpone assessment of unexplained loss.
Risks and what can go wrong
Short trials reported relatively few problems, but their size and duration limit what they can tell us about uncommon or long-term effects. In the 24-week helmet trial, reported effects included temporary shedding and an itchy scalp. The 16-week add-on trial reported no major adverse effects, although minor effects including headache, itching, redness and initial shedding occurred among participants (Suchonwanit and colleagues, 2019; Khandpur and colleagues, 2023).
These reports should not be read as proof that every device is harmless. Different light sources, construction, schedules and user instructions may carry different practical risks, while small trials may miss rare events. Follow the manufacturer’s safety instructions and seek clinical advice if you develop troubling symptoms.
Misdiagnosis is a larger concern than a disappointing gadget. Spending months on LLLT could delay assessment of another cause of hair loss. The NHS notes that temporary loss may follow illness, stress, weight loss or iron deficiency, while pattern baldness is generally permanent.
Cost and expectations can also go wrong. A seller may cite a study that tested a different model, quote improvement from baseline without the comparison result, or imply that research on androgenetic alopecia covers every cause of loss. Ask for the exact study, device name, participant diagnosis, comparison group, follow-up length and adverse-event reporting before relying on a claim.
LLLT is not evidence that a transplant is required or suitable. Hair transplantation carries surgical risks such as bleeding, infection, an allergic reaction to anaesthetic, scarring, graft failure and continued thinning, according to the NHS hair transplant guide. A partner clinic must assess transplant suitability separately.
Questions to ask the clinic
If a clinic suggests LLLT or you are comparing it with a transplant, ask:
- What diagnosis explains my hair loss, and who made that diagnosis?
- Which published trial tested this exact device and treatment schedule?
- Did that trial compare the device with a sham, no treatment or another active treatment?
- What change was measured, and how long were participants followed?
- Which side effects were reported, and what should I do if they occur?
- How will progress be measured without relying on changing lighting or sales photographs?
- Should I speak to my GP or a dermatologist before deciding?
- If surgery is being discussed, how has the clinic assessed it separately from any LLLT claim?
Talk it through
If androgenetic alopecia has been diagnosed and you want to understand whether a hair transplant belongs among your options, GetHair can arrange a free consultation with a partner clinic. The clinic assesses your hair loss and decides whether surgery is suitable; GetHair arranges the introduction.